Defining Proteomic Signatures to Predict Multidrug Persistence in Pseudomonas aeruginosa

Pablo Manfredi1, Isabella Santi1, Enea Maffei1

  • 1Biozentrum, University of Basel, Basel, Switzerland.

Insights

Bacterial persisters, small subpopulations surviving antibiotics, are hard to study. This new proteomic method analyzes whole populations to identify bacterial persistence signatures, aiding in antimicrobial resistance diagnostics.

Area of Science:

  • Microbiology
  • Proteomics
  • Machine Learning

Background:

  • Bacterial persisters are subpopulations that survive antibiotic treatment, posing a significant challenge in infectious disease management.
  • Studying persisters is difficult due to their small numbers and the experimental biases introduced by isolation methods.
  • Understanding the physiological state of persisters is crucial for developing effective eradication strategies.

Purpose of the Study:

  • To develop and validate a methodology for generating proteomic signatures of bacterial persisters in Pseudomonas aeruginosa.
  • To establish a proteomic approach that avoids biases associated with persister cell sorting and enrichment.
  • To create a diagnostic tool for assessing antimicrobial persistence in clinical isolates.

Main Methods:

  • Proteome sample preparation from entire bacterial populations.
  • Mass spectrometry analysis for high-throughput proteomic profiling.
  • An adaptable machine learning regression pipeline for data analysis.

Main Results:

  • The methodology successfully generated proteomic signatures for P. aeruginosa isolates with varying persister fractions.
  • A common proteomic signature of persistence was identified across different P. aeruginosa hyper-persister mutants.
  • The approach demonstrated the potential for analyzing entire populations to understand persistence.

Conclusions:

  • Proteome analysis of whole bacterial populations offers a sensitive and reproducible method to study bacterial persistence.
  • The developed methodology can identify common proteomic signatures associated with persistence.
  • This approach serves as a potential diagnostic tool for evaluating the antimicrobial persistence of clinical isolates.